Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $648000.0.

  • Sensus Healthcare's Current Deferred Revenue fell 553.94% to $648000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $648000.0, marking a year-over-year decrease of 553.94%. This contributed to the annual value of $541000.0 for FY2024, which is 1765.6% down from last year.
  • Latest data reveals that Sensus Healthcare reported Current Deferred Revenue of $648000.0 as of Q3 2025, which was down 553.94% from $529000.0 recorded in Q2 2025.
  • Over the past 5 years, Sensus Healthcare's Current Deferred Revenue peaked at $1.8 million during Q1 2021, and registered a low of $529000.0 during Q2 2025.
  • Moreover, its 5-year median value for Current Deferred Revenue was $808000.0 (2023), whereas its average is $992000.0.
  • As far as peak fluctuations go, Sensus Healthcare's Current Deferred Revenue skyrocketed by 4013.02% in 2021, and later tumbled by 4433.2% in 2025.
  • Over the past 5 years, Sensus Healthcare's Current Deferred Revenue (Quarter) stood at $1.4 million in 2021, then tumbled by 41.98% to $832000.0 in 2022, then fell by 21.03% to $657000.0 in 2023, then decreased by 17.66% to $541000.0 in 2024, then rose by 19.78% to $648000.0 in 2025.
  • Its Current Deferred Revenue stands at $648000.0 for Q3 2025, versus $529000.0 for Q2 2025 and $550000.0 for Q1 2025.